Work

A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1026255403046

Authors: Deborah K. Armstrong, John A. Blessing, Janet Rader, Joel I. Sorosky

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, Roswell Park Comprehensive Cancer Center, Washington University in St. Louis, University of Iowa Hospitals and Clinics

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1950154987, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, Gynecologic Oncology Group, G70736214

OpenAlex ID: W295024213

FWCI: 2.832

Cites: 14

Cited by: 20

Related to: 10